Absci Corp share price logo

Absci Corp

NASDAQ: ABSI

Small Cap

$5.87

+0.25

(+4.55%)

Live

as on

Absci Corp Stock Performance

as on May 7, 2026 at 1:07 am IST

  • Day's Low

    Day's High

    $5.60
    $5.89
    downward going graph

    4.60%

    Downside

    0.34%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.24
    $5.75
    downward going graph

    61.84%

    Downside

    -2.04%

    Upside

    downward going graph

Absci Corp share price movements today

Previous Close
$5.61
Open
$5.65
Volume
1.1M
Day's Low - High
$5.60 - $5.89
52 Week Low - High
$2.24 - $5.75

Absci Corp Historical Returns

1 Month Return
+ 89.53 %
3 Month Return
+ 108.16 %
1 Year Return
+ 111.7 %
3 Year Return
+ 303.6 %
5 Year Return
0 %

Absci Corp Stock Fundamentals & Key Indicators

Check Absci Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$873.6M

EPS (TTM)

-0.801

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-113.0M

Revenue (TTM)

2.8M

Profit Margin

0.00%

Return On Equity TTM

-62.50%

Absci Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Absci Corp with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Absci Corp image
Absci Corp
BUY$873.6MNANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$40.2B127.94%75.8512.55%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$107.9B99.08%25.1832.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$33.1BNA120.445.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$73.6B40.83%17.1329.65%

Stock Returns calculator for Absci Corp Stock including INR - Dollar returns

The Absci Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Absci Corp investment value today

Current value as on today

₹2,48,586

Returns

₹1,48,586

(+148.59%)

Returns from Absci Corp Stock

₹1,21,509 (+121.51%)

Dollar Impact

₹27,076 (+27.08%)

Analyst Recommendation on Absci Corp Stock

Based on 12 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Absci Corp. Average target price of $8.03

Absci Corp Share Price Target

Get share price movements and forecasts by analysts on Absci Corp.

What analysts predicted

26.9%UPSIDE

Target Price

$8.03

Current Price

$5.87

Analyzed by

12 Analysts

Target

$8.03

Absci Corp target price $8.03, a slight upside of 26.9% compared to current price of $5.87. According to 12 analysts rating.

Indian Investors' Interest in Absci Corp Stock

Search interest for Absci Corp Stock has increased by 38% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:38% versus previous 30 day period

Absci Corp Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
0
0
0
1
1
0
1
0
0
0
Gross Profit
-10
-11
-11
-13
-1
-16
-15
-19
0
-2
Operating Income
-23
-24
-23
-26
-28
-29
-27
-31
-30
-36
EBITDA
-19
-20
-20
-23
-23
-25
-24
-28
-25
-34
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
3
3
3
3
3
3
3
3
2
2
Income Before Tax
-21
-23
-21
-24
-27
-28
-26
-30
-28
-29
Income Tax Expense
0
0
0
24
0
0
0
0
0
0
Net Income
-21
-23
-21
-24
-27
-28
-26
-30
-28
-29
Net Profit Margin
-2956.18%
-6965.98%
-2447.10%
-1948.82%
-1610.70%
-4358.35%
-2234.61%
-5154.97%
-7594.18%
-4548.00%

Absci Corp Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
2
4
4
5
5
4
2
Gross Profit
2
-6
-39
-53
-41
-57
-8
Operating Income
-6
-13
-75
-106
-115
-108
-124
EBITDA
-5
-12
-67
-93
-79
-94
-112
Interest Expense
0
0
3
0
1
0
0
Depreciation
0
1
6
13
14
13
11
Income Before Tax
-6
-14
-109
-105
-110
-103
-115
Income Tax Expense
0
0
-8
0
0
0
0
Net Income
-6
-14
-100
-104
-110
-103
-115
Net Profit Margin
-319.61%
-300.27%
-2111.25%
-1825.37%
-1933.65%
-2274.06%
-4113.68%

Absci Corp Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-23
-21
-24
-27
-28
-26
-30
-28
-29
Operating Cash Flow
-14
-17
-16
-20
-16
-21
-16
-25
-29
Investing Cash Flow
18
-76
1
14
19
-15
9
-63
19
Financing Cash Flow
-1
81
0
0
0
42
-1
60
3
Change in Cash
2
-13
-15
-5
3
5
-8
-28
-5

Absci Corp Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-14
-100
-104
-110
-103
-115
Operating Cash Flow
-10
-60
-81
-64
-72
-92
Investing Cash Flow
-2
-67
-126
81
-41
-50
Financing Cash Flow
70
336
5
-4
82
105
Change in Cash
57
208
-203
12
-31
-37

Global Institutional Holdings in Absci Corp

Funds
Holdings
BlackRock Inc
6.81%
Baker Bros Advisors LP
1.37%
Bank of America Corp
1.25%
Redmile Group, LLC
5.31%
Woodline Partners LP
1.47%
See all

Absci Corp News & Key Events

  • img

    Today's Timeline - 11 September

    Thu, 09:30 PM

    -

    Absci collaborates with Oracle and AMD to enhance its generative AI Drug Creation Platform, accelerating drug discovery processes.

Insights on Absci Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, ABSI stock has moved up by 19.1%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 378.0K → 650.0K (in $), with an average increase of 41.9% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ABSI has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ABSI has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -28.70M → -29.56M (in $), with an average decrease of 3.0% per quarter

About Absci Corp

Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.
OrganisationAbsci Corp
Headquarters18105 SE Mill Plain Boulevard, Vancouver, WA, United States, 98683
IndustryBiotechnology
CEOMr. Sean McClain
E-voting on sharesClick here to vote

Key Management of Absci Corp

Name

Title

Dr. Zachariah Jonasson Ph.D.

Chief Business Officer & CFO

Mr. Todd Bedrick CPA

Senior VP & Chief Accounting Officer

Ms. Jeanne Schreuder M.B.A., SPHR

Senior Vice President of People & Experience

Dr. Christine Lemke D.V.M., M.B.A., Ph.D.

Senior Vice President of Portfolio & Growth Strategy

Mr. Sean McClain

Founder, CEO, President & Director

Ms. Shelby Walker J.D.

Chief Legal Officer

Mr. Wen Sha

Chief of Staff

Amir Shanehsazzadeh

Chief AI Officer

Dr. Ransi Somaratne FACC, M.B.A., M.D.

Chief Medical Officer

Mr. Alexander Khan CPA

CVP of Finance & Head of Investor Relations

FAQs

What is Absci Corp share price today?

Absci Corp share price today is $5.87 as on . Absci Corp share today touched a day high of $5.89 and a low of $5.6.

What is the 52 week high and 52 week low for Absci Corp share?

Absci Corp share touched a 52 week high of $5.75 on and a 52 week low of $2.24 on . Absci Corp stock price today i.e. is trending at $5.87,which is -2.09% down from its 52 week high and 162.05% up from its 52 week low.

What is Absci Corp's market capitalisation today?

Absci Corp market capitalisation is $0.00T as on .

How to invest in Absci Corp Stock (ABSI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Absci Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Absci Corp Shares that will get you 0.2555 shares as per Absci Corp share price of $5.87 per share as on May 6, 2026 at 7:37 pm IST.

What is the minimum amount required to buy Absci Corp Stock (ABSI) from India?

Indian investors can start investing in Absci Corp (ABSI) shares with as little as ₹94.61 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.10 in Absci Corp stock (as per the Rupee-Dollar exchange rate as on ). Based on Absci Corp share’s latest price of $5.87 as on May 6, 2026 at 7:37 pm IST, you will get 1.7036 shares of Absci Corp. Learn more about fractional shares .